The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo

Schizophrenia Research

Volumn 195, Issue , 2018, Pages 543-548

  McHugh, M J ^a   McGorry, P D ^a   Yuen, H P ^a   Hickie, I B ^b   Thompson, A ^c   de Haan, L ^d   Mossaheb, N ^e   Smesny, S ^f   Lin, A ^g   Markulev, C ^a   Schloegelhofer, M ^e   Wood, S J ^h,i   Nieman, D ^d   Hartmann, J A ^a   Nordentoft, M ^j,k   Schafer M ^a   Amminger, G P ^a   Yung, A ^l   Nelson, B ^a  

^a THE NATIONAL CENTRE OF EXCELLENCE IN YOUTH MENTAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WARWICK   (United Kingdom)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f JENA UNIVERSITY HOSPITAL   (Germany)

^g UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j Mental Health Centre Copenhagen   (Denmark)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l UNIVERSITY OF MANCHESTER   (United Kingdom)

more..

Author keywords

Long term outcomes; Symptom severity; Transition; UHR; Ultra High Risk for psychosis

Indexed keywords

ADULT; ARTICLE; ATTENUATED PSYCHOTIC SYMPTOMS; BRIEF LIMITED INTERMITTENT PSYCHOTIC SYMPTOMS; CONTROLLED STUDY; DISEASE SEVERITY; DISEASE SEVERITY ASSESSMENT; FEMALE; FOLLOW UP; GLOBAL ASSESSMENT OF FUNCTIONING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE ASSESSMENT; QUALITY OF LIFE SCALE; SCHEDULE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; SOCIAL PSYCHOLOGY; ADOLESCENT; COHORT ANALYSIS; INTERNATIONAL COOPERATION; PRODROMAL SYMPTOM; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INTERNATIONAL COOPERATION; MALE; PRODROMAL SYMPTOMS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 85031741582     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2017.09.003     Document Type: Article

References (47)

1. American Psychiatric Association, Diagnostic Stastistical Manual of Mental Disorders. 4th ed, 1994, Author, Washington DC.
2. Andreasen, N.C., Negative symptoms in schizophrenia. Definition and reliability. Arch. Gen. Psychiatry 39 (1982), 784–788.
3. Andreasen, N.C., Flaum, M., Arndt, S., The Comprehensive Assessment Of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch. Gen. Psychiatry 49 (1992), 615–623.
4. Berger, G.E., Wood, S.J., Ross, M., Hamer, C.A., Wellard, R.M., Pell, G., Phillips, L., Nelson, B., Amminger, G.P., Yung, A.R., Jackson, G., Velakoulis, D., Pantelis, C., Manji, H., McGorry, P.D., Neuroprotective effects of low-dose lithium in individuals at ultra-high risk for psychosis. A longitudinal MRI/MRS study. Curr. Pharm. Des. 18 (2012), 570–575.
5. de Wit, S., Schothorst, P.F., Oranje, B., Ziermans, T.B., Durston, S., Kahn, R.S., Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state. Eur. Neuropsychopharmacol. 24 (2014), 865–873, 10.1016/j.euroneuro.2014.02.008.
6. First, M., Spitzer, R., Gibbon, M., Williams, J., Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Research Version. Patient Edition, 2002, Biometrics Research, New York State Psychiatric Institute, New York, NY.
7. First, M., Spitzer, R., Gibbon, M., Williams, J.B.W., Structured Clinical Interview for DSM-IV Personality Disorders, (SCID-II). 1997, American Psychiatric Press, Inc., Washington, DC.
8. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., The structured clinical interview for DSM–III–R personality disorders (SCI-D–II). J. Personal. Disord. 9 (1995), 83–91.
9. Fusar-Poli, P., Borgwardt, S., Bechdolf, A., Addington, J., Riecher-Rössler, A., Schultze-Lutter, F., Keshavan, M., Wood, S., Ruhrmann, S., Seidman, L.J., Valmaggia, L., Cannon, T., Velthorst, E., De Haan, L., Cornblatt, B., Bonoldi, I., Birchwood, M., McGlashan, T., Carpenter, W., McGorry, P., Klosterkötter, J., McGuire, P., Yung, A., The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 70 (2013), 107–120, 10.1001/jamapsychiatry.2013.269.
10. Fusar-Poli, P., Cappucciati, M., Borgwardt, S., Woods, S.W., Addington, J., Nelson, B., Nieman, D.H., Stahl, D.R., Rutigliano, G., Riecher-Rössler, A., Simon, A.E., Mizuno, M., Lee, T.Y., Kwon, J.S., Lam, M.M.L., Perez, J., Keri, S., Amminger, P., Metzler, S., Kawohl, W., Rössler, W., Lee, J., Labad, J., Ziermans, T., An, S.K., Liu, C.-C., Woodberry, K.A., Braham, A., Corcoran, C., McGorry, P., Yung, A.R., McGuire, P.K., Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry 73 (2015), 1–8, 10.1001/jamapsychiatry.2015.2324.
11. Fusar-Poli, P., Rutigliano, G., Stahl, D., Davies, C., De Micheli, A., Ramella-Cravaro, V., Bonoldi, I., McGuire, P., Long-term validity of the At Risk Mental State (ARMS) for predicting psychotic and non-psychotic mental disorders. Eur. Psychiatry 42 (2017), 49–54, 10.1016/j.eurpsy.2016.11.010.
12. Hartmann, J.A., Nelson, B., Spooner, R., Amminger, G.P., Chanen, A.M., Davey, C., McHugh, M., Ratheesh, A., Treen, D., Yuen, H.P., McGorry, P.D., Beyond Psychosis Risk: Methodlogy of a Cohort Study Validating Criteria for a Pluripotent At-risk Mental State. 2017 (In Press).
13. Heinrichs, D.W., Hanlon, T.E., Carpenter, W.T., The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schizophr. Bull. 10 (1984), 388–398.
14. Initiative, N.G., Family Interview for Genetic Studies. 1992, NIMH, Rockville, MD.
15. Lin, A., Wood, S.J., Nelson, B., Beavan, A., McGorry, P., Yung, A.R., Outcomes of nontransitioned cases in a sample at ultra-high risk for psychosis. Am. J. Psychiatry 172 (2015), 249–258, 10.1176/appi.ajp.2014.13030418.
16. Lincoln, T.M., Dollfus, S., Lyne, J., Current developments and challenges in the assessment of negative symptoms. Schizophr. Res. 186 (2017), 8–18.
17. Markulev, C., McGorry, P.D., Nelson, B., Yuen, H.P., Schaefer, M., Yung, A.R., Thompson, A.D., Berger, G.E., Mossaheb, N., Schlögelhofer, M., Smesny, S., de Haan, L., Riecher-Rössler, A., Nordentoft, M., Chen, E., Verma, S., Hickie, I., Amminger, P., The NEURAPRO-E Study Protocol: A Multicenter RCT of Omega-3 Fatty Acids and Cognitive-Behavioural Case Management for Patients at Ultra High Risk of Schizophrenia and Other Psychotic Disorders. 2015, Psychiatry In Press, Early Interv.
18. McGorry, P.D., Hickie, I.B., Yung, A.R., Pantelis, C., Jackson, H.J., Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust. N. Z. J. Psychiatry 40 (2006), 616–622, 10.1111/j.1440-1614.2006.01860.x.
19. McGorry, P.D., Nelson, B., Why we need a transdiagnostic staging approach to emerging psychopathology, early diagnosis, and treatment. JAMA Psychiatry 73 (2016), 191–192, 10.1001/jamapsychiatry.2015.2868.
20. McGorry, P.D., Nelson, B., Markulev, C., Yuen, H.P., Schäfer, M.R., Mossaheb, N., Schlögelhofer, M., Smesny, S., Hickie, I.B., Berger, G.E., Chen, E.Y.H., de Haan, L., Nieman, D.H., Nordentoft, M., Riecher-Rössler, A., Verma, S., Thompson, A., Yung, A.R., Amminger, G.P., Effect of ω-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders. JAMA Psychiatry, 74, 2017, 19, 10.1001/jamapsychiatry.2016.2902.
21. McGorry, P.D., Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S., Cosgrave, E.M., Germano, D., Bravin, J., McDonald, T., Blair, A., Adlard, S., Jackson, H., Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch. Gen. Psychiatry 59 (2002), 921–928.
22. Nelson, B., Yuen, H.P., Lin, A., Wood, S.J., McGorry, P.D., Hartmann, J.A., Yung, A.R., Further examination of the reducing transition rate in ultra high risk for psychosis samples: the possible role of earlier intervention. Schizophr. Res. 174 (2016), 43–49, 10.1016/j.schres.2016.04.040.
23. Nelson, B., Yuen, H.P., Wood, S.J., Lin, A., Spiliotacopoulos, D., Bruxner, A., Broussard, C., Simmons, M., Foley, D.L., Brewer, W.J., Francey, S.M., Amminger, G.P., Thompson, A., McGorry, P.D., Yung, A.R., Long-term follow-up of a group at ultra high risk (“prodromal”) for psychosis: the PACE 400 study. JAMA Psychiatry 70 (2013), 793–802, 10.1001/jamapsychiatry.2013.1270.
24. Nelson, B., Yuen, K., Yung, A.R., Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis?. Schizophr. Res. 125 (2011), 62–68, 10.1016/j.schres.2010.10.017.
25. Overall, J.E., Gorhum, D.R., The brief psychiatric rating scale. Psychol. Rep. 10 (1962), 799–812, 10.2466/pr0.1962.10.3.799.
26. Phillips, L.J., Nelson, B., Yuen, H.P., Francey, S.M., Simmons, M., Stanford, C., Ross, M., Kelly, D., Baker, K., Conus, P., Amminger, P., Trumpler, F., Yun, Y., Lim, M., McNab, C., Yung, A.R., McGorry, P.D., Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: study design and baseline characteristics. Aust. N. Z. J. Psychiatry 43 (2009), 818–829, 10.1080/00048670903107625.
27. Rutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., Rocchetti, M., De Micheli, A., Jones, C., Palombini, E., McGuire, P., Fusar-Poli, P., Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J. Affect. Disord. 203 (2016), 101–110, 10.1016/j.jad.2016.05.053.
28. Rutigliano, G., Valmaggia, L., Landi, P., Frascarelli, M., Cappucciati, M., Sear, V., Rocchetti, M., De Micheli, A., Jones, C., Palombini, E., McGuire, P., Fusar-Poli, P., Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis. J. Affect. Disord. 203 (2016), 101–110, 10.1016/j.jad.2016.05.053.
29. Schultze-Lutter, F., Michel, C., Schmidt, S.J., Schimmelmann, B.G., Maric, N.P., Gaag, M. Van Der, Nordentoft, M., Raballo, A., Meneghelli, A., Marshall, M., Morrison, A., Ruhrmann, S., Klosterko, J., Original article EPA guidance on the early detection of clinical high risk states of psychoses. Eur. Psychiatry 30 (2015), 405–416, 10.1016/j.eurpsy.2015.01.010.
30. Seidman, L.J., Giuliano, A.J., Meyer, E.C., Addington, J., Cadenhead, K.S., Cannon, T.D., McGlashan, T.H., Perkins, D.O., Tsuang, M.T., Walker, E.F., Woods, S.W., Bearden, C.E., Christensen, B.K., Hawkins, K., Heaton, R., Keefe, R.S.E., Heinssen, R., Cornblatt, B.A., Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch. Gen. Psychiatry 67 (2010), 578–588, 10.1001/archgenpsychiatry.2010.66.
31. Shah, J.L., Crawford, A., Mustafa, S.S., Iyer, S.N., Joober, R., Malla, A.K., Is the clinical high-risk state a valid concept? Retrospective examination in a first-episode psychosis sample. Psychiatr. Serv., 2017 appi.ps.2016003 http://dx.doi.org/10.1176/appi.ps.201600304.
32. Simon, A.E., Umbricht, D., Lang, U.E., Borgwardt, S., Declining transition rates to psychosis: the role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome. Schizophr. Res. 159 (2014), 292–298, 10.1016/j.schres.2014.09.016.
33. Simon, A.E., Velthorst, E., Nieman, D.H., Linszen, D., Umbricht, D., de Haan, L., Ultra high-risk state for psychosis and non-transition: a systematic review. Schizophr. Res. 132 (2011), 8–17, 10.1016/j.schres.2011.07.002.
34. Thompson, K.N., Phillips, L.J., Komesaroff, P., Yuen, H.P., Wood, S.J., Pantelis, C., Velakoulis, D., Yung, A.R., McGorry, P.D., Stress and HPA-axis functioning in young people at ultra high risk for psychosis. J. Psychiatr. Res. 41 (2007), 561–569, 10.1016/j.jpsychires.2006.05.010.
35. van der Gaag, M., Smit, F., Bechdolf, A., French, P., Linszen, D.H., Yung, A.R., McGorry, P., Cuijpers, P., Preventing a first episode of psychosis: meta-analysis of randomized controlled prevention trials of 12 month and longer-term follow-ups. Schizophr. Res. 149 (2013), 56–62, 10.1016/j.schres.2013.07.004.
36. van Os, J., Guloksuz, S., A critique of the “ultra-high risk” and “transition” paradigm. World Psychiatry 16 (2017), 200–206.
37. van Prooijen, J.-W., Karremans, J.C., van Beest, I., Procedural justice and the hedonic principle: how approach versus avoidance motivation influences the psychology of voice. J. Pers. Soc. Psychol. 91 (2006), 686–697, 10.1037/0022-3514.91.4.686.
38. Wiltink, S., Velthorst, E., Nelson, B., McGorry, P.M., Yung, A.R., Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. Early Interv. Psychiatry 9 (2015), 200–206, 10.1111/eip.12105.
39. Yung, A.R., McGorry, P.D., The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr. Bull. 22 (1996), 353–370.
40. Yung, A.R., McGorry, P.D., The initial prodrome in psychosis: descriptive and qualitative aspects. Aust. New Zeal. J. Psychiatry 30 (1996), 587–599, 10.3109/00048679609062654.
41. Yung, A.R., Phillips, L.J., Nelson, B., Francey, S.M., PanYuen, H., Simmons, M.B., Ross, M.L., Kelly, D., Baker, K., Amminger, G.P., Berger, G., Thompson, A.D., Thampi, A., McGorry, P.D., Randomized controlled trial of interventions for young people at ultra high risk for psychosis: 6-month analysis. J. Clin. Psychiatry 72 (2011), 430–440, 10.4088/JCP.08m04979ora.
42. Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., McGorry, P.D., Psychosis prediction: 12-month follow up of a high-risk (“prodromal”) group. Schizophr. Res. 60 (2003), 21–32.
43. Yung, A.R., Phillips, L.J., Yuen, H.P., McGorry, P.D., Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 67 (2004), 131–142, 10.1016/S0920-9964(03)00192-0.
44. Yung, A.R., Woods, S.W., Ruhrmann, S., Addington, J., Schultze-Lutter, F., Cornblatt, A., Amminger, G.P., Bechdolf, A., Birchwood, M., Borgwardt, S., Cannon, T.D., Whither the attenuated psychosis syndrome?. Schizophr. Bull. 38 (2012), 1130–1134, 10.1093/schbul/sbs108.
45. Yung, A.R., Yuen, H.P., Berger, G., Francey, S., Hung, T.-C., Nelson, B., Phillips, L., McGorry, P., Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?. Schizophr. Bull. 33 (2007), 673–681, 10.1093/schbul/sbm015.
46. Yung, A.R., Yuen, H.P., McGorry, P.D., Phillips, L.J., Kelly, D., Dell'Olio, M., Francey, S., Cosgrove, E., Killackey, E., Stanford, C., Godfrey, K., Buckby, J., Mapping the onset of psychosis: the comprehensive assessment of at risk mental states (CAARMS). Schizophr. Res. 60 (2005), 30–31, 10.1016/S0920-9964(03)80090-7.
47. Zubin, J., Negative symptoms: are they indigenous to schizophrenia. Schizophr. Bull. 11 (1985), 461–470.